Medpace Holdings, Inc. Intangible Assets, Net (Excluding Goodwill)
Medpace Holdings, Inc. (MEDP) had Intangible Assets, Net (Excluding Goodwill) of $33.11 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-07-23
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $33.11M.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $33.27M.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $33.42M.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $33.66M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2026-06-30 | $33.11M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $33.27M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $33.42M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $33.66M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $33.89M 10-Q · filed 2025-07-22 |
| 2025-03-31 | $34.13M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $34.37M 10-K · filed 2026-02-10 |
| 2024-09-30 | $34.73M 10-Q · filed 2024-10-22 |
| 2024-06-30 | $35.09M 10-Q · filed 2024-07-23 |
| 2024-03-31 | $35.45M 10-Q · filed 2024-04-23 |
| 2023-12-31 | $35.81M 10-K · filed 2025-02-11 |
| 2023-09-30 | $36.36M 10-Q · filed 2023-10-24 |
| 2023-06-30 | $36.91M 10-Q · filed 2023-07-25 |
| 2023-03-31 | $37.46M 10-Q · filed 2023-04-25 |
| 2022-12-31 | $38.01M 10-K · filed 2024-02-13 |
| 2022-09-30 | $38.85M 10-Q · filed 2022-10-25 |
| 2022-06-30 | $39.68M 10-Q · filed 2022-07-26 |
| 2022-03-31 | $40.52M 10-Q · filed 2022-04-26 |
| 2021-12-31 | $41.36M 10-K · filed 2023-02-14 |
| 2021-09-30 | $42.64M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $43.92M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $45.20M 10-Q · filed 2021-04-27 |
| 2020-12-31 | $46.47M 10-K · filed 2022-02-15 |
| 2020-09-30 | $48.42M 10-Q · filed 2020-10-27 |
| 2020-06-30 | $50.37M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $52.35M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $54.35M 10-K · filed 2021-02-16 |
| 2019-09-30 | $57.34M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $60.34M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $63.34M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $69.18M 10-K · filed 2020-02-25 |
| 2018-09-30 | $76.57M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $83.96M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $91.35M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $98.74M 10-K · filed 2019-02-26 |
| 2017-09-30 | $108.23M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $117.68M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $126.62M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $136.07M 10-K · filed 2018-02-27 |
| 2016-09-30 | $148.74M 10-Q · filed 2016-11-03 |
| 2015-12-31 | $186.74M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |